Dirk Vanderschueren1, Jemima Gaytant, Steven Boonen, Katrien Venken. 1. Bone Research Unit, Laboratory for Experimental Medicine and Endocrinology, Department of Experimental Medicine, Katholieke Universiteit Leuven, Leuven, Belgium. dirk.vanderschueren@uz.kuleuven.ac.be
Abstract
PURPOSE OF REVIEW: The present review will focus on the most important recent findings with respect to skeletal androgen action. Many studies have indicated that part of the androgen action may be related to the conversion of androgens into estrogens. Therefore, some of the most recent findings of skeletal estrogen action relevant for male skeletal physiology will also be discussed. RECENT FINDINGS: Androgens and estrogens stimulate bone formation and inhibit bone resorption. Sex steroids may interact with different receptors, target cells and other bone anabolic pathways. Androgen receptor and estrogen receptor signalling appear to be important for male bone formation during growth. Sex steroid signalling may involve genomic and nongenomic pathways, interaction with mechanical loading, the growth hormone/insulin-like growth factor-I axis and/or other bone anabolic pathways. Estrogen receptor alpha in osteoclasts appears to regulate bone resorption in women but not men, whereas androgen receptor signalling in osteoblasts may only partly regulate bone resorption in males. SUMMARY: The latest developments indicate that androgens and estrogens are important for male bone metabolism and homeostasis and therefore selective estrogen receptor alpha and androgen receptor signalling remain interesting drug targets for the stimulation of bone formation and male skeletal integrity.
PURPOSE OF REVIEW: The present review will focus on the most important recent findings with respect to skeletal androgen action. Many studies have indicated that part of the androgen action may be related to the conversion of androgens into estrogens. Therefore, some of the most recent findings of skeletal estrogen action relevant for male skeletal physiology will also be discussed. RECENT FINDINGS: Androgens and estrogens stimulate bone formation and inhibit bone resorption. Sex steroids may interact with different receptors, target cells and other bone anabolic pathways. Androgen receptor and estrogen receptor signalling appear to be important for male bone formation during growth. Sex steroid signalling may involve genomic and nongenomic pathways, interaction with mechanical loading, the growth hormone/insulin-like growth factor-I axis and/or other bone anabolic pathways. Estrogen receptor alpha in osteoclasts appears to regulate bone resorption in women but not men, whereas androgen receptor signalling in osteoblasts may only partly regulate bone resorption in males. SUMMARY: The latest developments indicate that androgens and estrogens are important for male bone metabolism and homeostasis and therefore selective estrogen receptor alpha and androgen receptor signalling remain interesting drug targets for the stimulation of bone formation and male skeletal integrity.
Authors: S Benvenuti; I Cellai; P Luciani; C Deledda; R Saccardi; B Mazzanti; S Dal Pozzo; M Serio; A Peri Journal: J Endocrinol Invest Date: 2011-05-19 Impact factor: 4.256
Authors: Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano Journal: Front Pharmacol Date: 2018-09-19 Impact factor: 5.810
Authors: Kelen Jorge Rodrigues da Costa; Joel J Passos; Alinne D M Gomes; Rubén D Sinisterra; Célia R M Lanza; Maria Esperanza Cortés Journal: J Mater Sci Mater Med Date: 2012-08-11 Impact factor: 3.896
Authors: Nadiya M Teplyuk; Ying Zhang; Yang Lou; John R Hawse; Mohammad Q Hassan; Viktor I Teplyuk; Jitesh Pratap; Mario Galindo; Janet L Stein; Gary S Stein; Jane B Lian; Andre J van Wijnen Journal: Mol Endocrinol Date: 2009-04-02
Authors: Emanuele M Gargano; Giuseppe Allegretta; Enrico Perspicace; Angelo Carotti; Chris Van Koppen; Martin Frotscher; Sandrine Marchais-Oberwinkler; Rolf W Hartmann Journal: PLoS One Date: 2015-07-31 Impact factor: 3.240